Palisade Bio Inc
General ticker "PALI" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.0M
Palisade Bio Inc does not follow the US Stock Market performance with the rate: -40.2%.
Estimated limits based on current volatility of 6.8%: low 1.72$, high 1.97$
Factors to consider:
- Current price 50.3% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.52$, 14.49$]
- 2024-12-30 to 2025-12-30 estimated range: [1.60$, 6.24$]
Financial Metrics affecting the PALI estimates:
- Negative: Non-GAAP EPS, $ of -27.15 <= 0.10
- Negative: Operating profit margin, % of -98.12 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -72.99 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: 0 < Interest expense per share, $ of 0.03
Short-term PALI quotes
Long-term PALI plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.25MM |
Operating Expenses | $41.85MM | $15.72MM | $13.32MM |
Operating Income | $-41.85MM | $-15.72MM | $-13.07MM |
Non-Operating Income | $15.24MM | $1.46MM | $0.77MM |
Interest Expense | $2.40MM | $0.01MM | $0.01MM |
R&D Expense | $32.55MM | $6.55MM | $6.89MM |
Income(Loss) | $-26.62MM | $-14.26MM | $-12.30MM |
Taxes | $0.66MM | $-1.46MM | $0.00MM |
Profit(Loss) | $-27.27MM | $-12.80MM | $-12.30MM |
Stockholders Equity | $7.37MM | $12.48MM | $11.31MM |
Inventory | $0.15MM | $1.44MM | $0.00MM |
Assets | $12.51MM | $15.76MM | $14.05MM |
Operating Cash Flow | $-14.77MM | $-13.36MM | $-11.13MM |
Capital expenditure | $0.00MM | $0.01MM | $0.00MM |
Investing Cash Flow | $-0.05MM | $-0.01MM | $-0.00MM |
Financing Cash Flow | $24.61MM | $15.26MM | $11.19MM |
Earnings Per Share* | $-2,608.92 | $-218.14 | $-27.01 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.